News

As per a new agreement, Ampac Fine Chemicals is expected to use Codexis’ proprietary biocatalysis technology in combination with AFC’s existing technologies to reduce cost, increase manufacturing efficiency

The filing of the IND follows a successful Pre-IND meeting with the FDA, during which guidance was provided to the company regarding the basis of approval and the

Pursuant to the agreements, Parenteral is authorised to register, supply and distribute Sinovac’s Anflu (seasonal influenza vaccine) and Panflu1 (H1N1 vaccine) to the government of India and private

The clinical trial is taking place at the Hadassah Hebrew University Medical Centre in Jerusalem under an agreement between Immuron and Hadasit, the Medical Centre’s commercialisation arm. Immuron

Bayer Schering Pharma said that these prospective cohort studies conducted by independent investigators found that the risk for venous thromboembolism (VTE) in Yasmin users is comparable to the

The patent identifies and protects peptides that were discovered using MDRNA’s proprietary Trp Cage Phage Display Library and describes targeting peptides that demonstrate high binding affinity to, and

Initially, Actelion had signed contract with Invida in 2005 and has extended it to market Tracleer in Thailand, Malaysia, Philippines, Vietnam and Hong Kong Invida is expected to

Reportedly, GSK had filed a supplemental new drug application (sNDA) for Avodart (dutasteride) with the FDA on 1 October, 2009. GSK said that the re-submission provides an update

The new unit will comprise three manufacturing clean rooms, and microbiological and chemical laboratories. Vetter said that the facility features a fully automated production line that automates processes